Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2021-04-07 | 2021-04-07 |
| Drug Identification Number | 00717282 | 00717282 |
| Brand name | PRIMAXIN 500 | PRIMAXIN 500 |
| Common or Proper name | imipenem and cilastatin sodium for injection | imipenem and cilastatin sodium for injection |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | IMIPENEM CILASTATIN | IMIPENEM CILASTATIN |
| Strength(s) | 500MG 500MG | 500MG 500MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 25 vial | 25 vial |
| ATC code | J01DH | J01DH |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2021-04-19 | 2021-04-19 |
| Actual start date | ||
| Estimated end date | 2021-04-30 | 2021-04-30 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |